NCT00940680

Efficacy/Safety of Amlodipine Plus Losartan Versus Losartan in Patients With Essential Hypertension

A Phase III, 8-week, Multicenter, Randomized, Double-blind Study to Compare the Efficacy and Safety of Amlodipine 5mg+Losartan 100mg Versus Losartan 100mg in Patients With Essential Hypertension Not Controlled on Losartan Monotherapy

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 142 (actual)
• Sponsor: Hanmi Pharmaceutical Company Limited · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate of efficacy and safety of amlodipine plus losartan and losartan alone in patients with essential hypertension inadequately controlled on losartan monotherapy.

Conditions

• Hypertension

Interventions

Type	Name	Description
DRUG	Amlodipine plus Losartan	amlodipine/losartan 5/100mg q.d.
DRUG	Losartan	losartan 100mg q.d.

Timeline

• Start date: 2008-04-01
• Primary completion: 2008-11-01
• Completion: 2008-11-01
• First posted: 2009-07-16
• Last updated: 2009-07-16

Locations

1 site across 1 country: South Korea